These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28456733)

  • 21. Effects of temperature and osmolytes on competing degradation routes for an IgG1 antibody.
    Roberts CJ; Nesta DP; Kim N
    J Pharm Sci; 2013 Oct; 102(10):3556-66. PubMed ID: 23873602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scattering.
    Nemergut M; Žoldák G; Schaefer JV; Kast F; Miškovský P; Plückthun A; Sedlák E
    Protein Sci; 2017 Nov; 26(11):2229-2239. PubMed ID: 28833802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
    Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
    Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Freeze/Thaw Process on Drug Substance Storage of Therapeutics.
    Rayfield WJ; Kandula S; Khan H; Tugcu N
    J Pharm Sci; 2017 Aug; 106(8):1944-1951. PubMed ID: 28343990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein-protein interactions and water activity coefficients can be used to aid a first excipient choice in protein formulations.
    Schleinitz M; Sadowski G; Brandenbusch C
    Int J Pharm; 2019 Oct; 569():118608. PubMed ID: 31415881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies.
    Banks DD; Latypov RF; Ketchem RR; Woodard J; Scavezze JL; Siska CC; Razinkov VI
    J Pharm Sci; 2012 Aug; 101(8):2720-32. PubMed ID: 22648863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration.
    Zidar M; Šušterič A; Ravnik M; Kuzman D
    Pharm Res; 2017 Sep; 34(9):1831-1839. PubMed ID: 28593474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation development of antibodies using robotic system and high-throughput laboratory (HTL).
    Zhao H; Graf O; Milovic N; Luan X; Bluemel M; Smolny M; Forrer K
    J Pharm Sci; 2010 May; 99(5):2279-94. PubMed ID: 20014026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Virus-like particle formulation optimization by miniaturized high-throughput screening.
    Mohr J; Chuan YP; Wu Y; Lua LH; Middelberg AP
    Methods; 2013 May; 60(3):248-56. PubMed ID: 23639868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.
    Dasnoy S; Le Bras V; Préat V; Lemoine D
    Biotechnol Bioeng; 2012 Feb; 109(2):502-16. PubMed ID: 21928339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1.
    Hu Y; Arora J; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):340-352. PubMed ID: 31201906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated Aggregation Studies of Monoclonal Antibodies: Considerations for Storage Stability.
    Wälchli R; Vermeire PJ; Massant J; Arosio P
    J Pharm Sci; 2020 Jan; 109(1):595-602. PubMed ID: 31676272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Crystal Zenith Microtiter Plates for High-Throughput Formulation Screening.
    Floyd JA; Shaver JM; Gillespie AJ; Park U; Rogers RS; Nightlinger NS; Ogata Y; James JJ; Kerwin BA
    J Pharm Sci; 2020 Jan; 109(1):532-542. PubMed ID: 31669607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surfactant Impact on Interfacial Protein Aggregation and Utilization of Surface Tension to Predict Surfactant Requirements for Biological Formulations.
    Vargo KB; Stahl P; Hwang B; Hwang E; Giordano D; Randolph P; Celentano C; Hepler R; Amin K
    Mol Pharm; 2021 Jan; 18(1):148-157. PubMed ID: 33253579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-Term Storage.
    Svilenov HL; Kulakova A; Zalar M; Golovanov AP; Harris P; Winter G
    J Pharm Sci; 2020 Jan; 109(1):584-594. PubMed ID: 31689429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive Nature of High-Throughput Assays in ADC Formulation Screening.
    Mills BJ; Godamudunage MP; Ren S; Laha M
    J Pharm Sci; 2023 Jul; 112(7):1821-1831. PubMed ID: 37037342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary: New perspectives on protein aggregation during Biopharmaceutical development.
    Shah M
    Int J Pharm; 2018 Dec; 552(1-2):1-6. PubMed ID: 30253208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin.
    Serno T; Carpenter JF; Randolph TW; Winter G
    J Pharm Sci; 2010 Mar; 99(3):1193-206. PubMed ID: 19774651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.